EP2935549B1 - Method for removing fat and/or oil stains - Google Patents

Method for removing fat and/or oil stains Download PDF

Info

Publication number
EP2935549B1
EP2935549B1 EP13803053.1A EP13803053A EP2935549B1 EP 2935549 B1 EP2935549 B1 EP 2935549B1 EP 13803053 A EP13803053 A EP 13803053A EP 2935549 B1 EP2935549 B1 EP 2935549B1
Authority
EP
European Patent Office
Prior art keywords
arginine
sri
fabric
stain
stain removal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP13803053.1A
Other languages
German (de)
French (fr)
Other versions
EP2935549A1 (en
Inventor
Ravine Anthony Gungabissoon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever PLC
Unilever NV
Original Assignee
Unilever PLC
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever PLC, Unilever NV filed Critical Unilever PLC
Priority to EP13803053.1A priority Critical patent/EP2935549B1/en
Publication of EP2935549A1 publication Critical patent/EP2935549A1/en
Application granted granted Critical
Publication of EP2935549B1 publication Critical patent/EP2935549B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/26Organic compounds containing nitrogen
    • C11D3/33Amino carboxylic acids

Definitions

  • This invention relates to fabric stain removal methods for ambient-active fat/oil based stains, particularly but not exclusively as a pre-treatment or direct application.
  • aqueous substrate cleaning is performed at cold or ambient temperatures. These temperatures are a challenge for fat/oil stain removal technology which relies on water temperatures of 40 - 70 degrees. In the case of modern washing machines, stain removal mainly relies largely on the heating of water above ambient temperatures in the washing machine. This accounts for a large proportion of the laundry related greenhouse gas footprint which needs reducing for environmental reasons.
  • the objective of the invention is the removal of fabric stains from stained fabric, where the fabric stains comprise fat/oil.
  • the invention provides a method for removing a stain comprising fat/oil from a stained fabric, comprising the step of applying to the stain, a fabric stain removal composition comprising an arginine compound and a surfactant.
  • the invention provides a method of the first aspect of the invention, wherein the step of applying the fabric stain removal composition is a pre-treatment step using a pre-treatment device, wherein the pre-treatment device comprises (i) a storage chamber storing said fabric stain removal composition and (ii) a dispenser for locally applying said fabric stain removal composition to a stain on a fabric.
  • the invention provides use of arginine compound, preferably in combination with a surfactant, in the removal of oil/fat stains from a stained fabric, preferably in the removal of fat stains, at ambient temperatures.
  • the removal of oil/fat stains at low temperatures is radically improved and so offers improved laundry cleaning in regions where ambient washing occurs out of habit or necessity. Improved washing performance at lower temperatures is generally desirable but increased low temperature performance may also help inhibit the adoption of hot water washing in these countries, a rising trend as standards of living increase and more people are able to afford washing machines.
  • the invention provides stain removal performance of fat based soil and/or stains in an ambient temperature cleaning processes (with low temperature wash liquor) without serious consideration to the temperature sensitivity of ingredients during storage.
  • the formulation can therefore be designed more freely, on the basis of other considerations.
  • substrate includes fabric, and clothing and other surfaces such as cutlery, crockery and other domestic hard surfaces.
  • arginine compound is intended to include any suitable arginine compound, including stereoisomeric and racemic forms, derivatives, and substituted derivative and mixtures thereof.
  • ambient-active is intended to mean less that 25 degrees Celcius and preferably 22 degrees Celcius or less, more preferably 15 degrees or less but always greater than 1 degree Celcius and "active" means effective in achieving stain removal.
  • stain removal is means removal as measured in terms of Remission units or a Remission index. For a visible (by the human eye) effect, effective stain removal is represented by remission equal to or greater than 2 Remission units and preferably greater or equal to 5 units.
  • wt% means “% by weight”. Unless specified otherwise, all percentages mentioned herein are by weight calculated relative to the total composition.
  • the stain may comprise oil or fat, preferably fat. However, it is often found that other biological material may be included in the stain.
  • the method of the invention preferably comprises an aqueous washing process. Accordingly it is preferred that the method comprises the step of adding water to the composition to form an aqueous wash liquor
  • the method comprises localised application of the composition to a stain or stained area of the fabric.
  • the method may be pre-treatment method, and be followed by a subsequent aqueous washing step. Pre-treatment steps may take place without further addition of any water (beyond any contained in the composition).
  • the pre-treatment process may comprise the step of soaking the substrate in an aqueous solution to which the treatment composition has been added.
  • the second step of the method of the invention may be a 'main' wash and may be a manual washing process or a washing process in a washing machine.
  • the second step may use any suitable detergent composition.
  • this detergent composition comprises one or more surfactants and/or other functional ingredients, adjuncts etc. as described below.
  • the method of the invention is less than 90 minutes in duration, more preferably less than 60 minutes and most preferably less than 30 minutes.
  • the pre-treatment step is preferably less than 5 minutes, and more preferably less than 2 minutes.
  • the pre-treatment device may be by any suitable device such as roll-on applicator or tube, sprays, aerosols, pastes, a pump-operated dispenser or the like.
  • the pre-treatment device may comprise a scrubbing member having brush, bristles, tufts, projections, embossments etc or any combination thereof to further aid application of the detergent composition to a substrate.
  • the treatment composition is ambient-active. Accordingly, the temperature of the wash liquor step of aqueous washing process is therefore less than 40 °C and preferably less than 30 °C and more preferably less than 25 °C and more preferably less than or equal to 22 °C further more preferably 15°C or less at all times during the washing but excluding drying. Encouraging low temperature wash liquor is advantageous environmentally and financially.
  • the treatment composition of the invention and/or any detergent composition used subsequently may comprise any of the following ingredients.
  • compositions may comprise enzymes.
  • the enzymes are preferably present at 0.001 - 5%wt more preferably 0.01 - 3%.
  • Enzymes may be from animal, vegetable, bacterial origin (derived from bacteria) or fungal origin (derived from fungus) however enzymes from bacterial origin are preferred. Chemically modified or protein engineered mutants are included. Genes encoding such enzymes can be transferred from one host to a preferred expression production host which may or may not be the same as the original host.
  • the term "enzyme” includes enzyme variants (produced, for example, by recombinant techniques) are included. Examples of such enzyme variants are disclosed, e.g., in EP 251,446 (Genencor), WO 91/00345 (Novo Nordisk), EP 525,610 (Solvay) and WO 94/02618 (Gist-Brocades NV).
  • the one or more enzymes preferably comprise a protease.
  • Preferred proteases are serine proteases or metallo proteases, preferably an alkaline microbial protease or a trypsin-like protease.
  • protease enzymes include AlcalaseTM, SavinaseTM, PrimaseTM, DuralaseTM, DyrazymTM, EsperaseTM, EverlaseTM, PolarzymeTM, and KannaseTM, (Novozymes A/S), MaxataseTM, MaxacalTM, MaxapemTM, ProperaseTM, PurafectTM, Purafect OxPTM, FN2TM, and FN3TM (Genencor International Inc.).
  • the one or more enzymes preferably comprises an amylase.
  • Suitable amylases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included.
  • Amylases include, for example, alpha-amylases obtained from Bacillus, e.g. a special strain of B. licheniformis, described in more detail in GB 1,296,839 , or the Bacillus sp. strains disclosed in WO 95/026397 or WO 00/060060 .
  • amylases are DuramylTM, TermamylTM, Termamyl UltraTM, NatalaseTM, StainzymeTM, FungamylTM and BANTM (Novozymes A/S), RapidaseTM and PurastarTM (from Genencor International IncCommercially available amylases include StainzymeTM (Novozymes).
  • the one or more enzymes preferably comprise a lipase and in such cases, the preferred lipases include first wash lipases which comprise a polypeptide having an amino acid sequence which has at least 90 percent sequence identity with the wild-type lipase derived from Humicola lanuginosa strain DSM 4109 and compared to said wild-type lipase, comprises a substitution of an electrically neutral or negatively charged amino acid within 15 A of E1 or Q249 with a positively charged amino acid; and may further comprise:
  • lipases include lipases from Humicola (synonym Thermomyces ), e.g. from other H. lanuginosa ( T. lanuginosus ) strains or from H. insolens, a Pseudomonas lipase, e.g. from P. alcaligenes or P. pseudoalcaligenes, P. cepacia, P. stutzeri, P. fluorescens, Pseudomonas sp. strain SD 705 ( WO 95/06720 and WO 96/27002 ), P. wisconsinensis, a Bacillus lipase, e.g. from B.
  • subtilis ( Dartois et al. (1993), Biochemica et Biophysica Acta, 1131, 253-360 ), B. stearothermophilus ( JP 64/744992 ) or B. pumilus ( WO 91/16422 ).
  • lipase enzymes include LipolaseTM and Lipolase UltraTM, and the Bacterial enzyme, Lipomax ® ex Genecor. This is a bacterially derived Lipase, of variant M21L of the lipase of Pseudomonas alcaligenes as described in WO 94/25578 to Gist-Brocades (M.M.M.J. Cox, H.B.M. Lenting, L.J.S.M. Mulleners and J.M. van der Laan).
  • the one or more enzymes preferably comprise a phospholipase classified as EC 3.1.1.4 and/or EC 3.1.1.32.
  • phospholipase is an enzyme which has activity towards phospholipids.
  • Phospholipids such as lecithin or phosphatidylcholine, consist of glycerol esterified with two fatty acids in an outer (sn-1) and the middle (sn-2) positions and esterified with phosphoric acid in the third position; the phosphoric acid, in turn, may be esterified to an amino-alcohol.
  • Phospholipases are enzymes which participate in the hydrolysis of phospholipids.
  • phospholipases A1 and A2 which hydrolyze one fatty acyl group (in the sn-1 and sn-2 position, respectively) to form lysophospholipid
  • lysophospholipase or phospholipase B
  • Phospholipase C and phospholipase D release diacyl glycerol or phosphatidic acid respectively.
  • the one or more enzymes preferably comprise a cutinase. classified in EC 3.1.1.74.
  • the cutinase used according to the invention may be of any origin.
  • Preferably cutinases are of microbial origin, in particular of bacterial, of fungal or of yeast origin.
  • the one or more enzymes preferably comprise a cellulase preferably including those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g.
  • the one or more enzymes preferably comprise a peroxidase/oxidase are especially of bacterial origin. Chemically modified or protein engineered mutants are included.
  • An example of an oxidative bacterium is, but not limited to, are Aeromonas sp wherefrom oxidases can be sourced.
  • the one or more enzymes preferably comprise a pectate lyase (also called polygalacturonate lyases):
  • pectate lyases include pectate lyases that have been cloned from different bacterial genera such as Erwinia, Pseudomonas, Klebsiella and Xanthomonas, as well as from Bacillus subtilis ( Nasser et al. (1993) FEBS Letts. 335:319-326 ) and Bacillus sp. YA-14 ( Kim et al. (1994) Biosci. Biotech. Biochem. 58:947-949 ).
  • the pectate lyase comprises the pectate lyase disclosed in Heffron et al., (1995) Mol. Plant-Microbe Interact. 8: 331-334 and Henrissat et al., (1995) Plant Physiol. 107: 963-976 .
  • pectatel lyases are disclosed in WO 99/27083 and WO 99/27084 .
  • pectate lyases derived from Bacillus licheniformis
  • US patent no. 6,284,524 which document is hereby incorporated by reference
  • pectate lyase variants are disclosed in WO 02/006442 , especially the variants disclosed in the Examples in WO 02/006442 (which document is hereby incorporated by reference).
  • alkaline pectate lyases include BIOPREPTM and SCOURZYMETM L from Novozymes A/S, Denmark.
  • the one or more enzymes preferably comprise a Mannanase:
  • mannanases include mannanases of bacterial and fungal origin.
  • the mannanase is derived from a strain of the filamentous fungus genus Aspergillus, preferably Aspergillus niger or Aspergillus aculeatus ( WO 94/25576 ).
  • WO 93/24622 discloses a mannanase isolated from Trichoderma reseei. Mannanases have also been isolated from several bacteria, including Bacillus organisms. For example, Talbot et al., Appl. Environ. Microbiol., Vol.56, No. 11, pp.
  • JP-A-03047076 discloses a beta-mannanase derived from Bacillus sp.
  • JP-A-63056289 describes the production of an alkaline, thermostable beta-mannanase.
  • JP-A-63036775 relates to the Bacillus microorganism FERM P-8856 which produces beta-mannanase and beta-mannosidase.
  • JP-A-08051975 discloses alkaline beta-mannanases from alkalophilic Bacillus sp. AM-001.
  • a purified mannanase from Bacillus amyloliquefaciens is disclosed in WO 97/11164 .
  • WO 91/18974 describes a hemicellulase such as a glucanase, xylanase or mannanase active.
  • mannanases derived from Bacillus agaradhaerens, Bacillus licheniformis, Bacillus halodurans, Bacillus clausii, Bacillus sp., and Humicola insolens disclosed in WO 99/64619 .
  • Bacillus sp. mannanases concerned in the Examples in WO 99/64619 .
  • Examples of commercially available mannanases include MannawayTM available from Novozymes A/S Denmark.
  • the enzyme and any perfume/fragrance or pro-fragrance present may show some interaction and should be chosen such that this interaction is not negative. Some negative interactions may be avoided by encapsulation of one or other of enzyme and pro-fragrance and/or other segregation within the product.
  • the enzymes may be provided as an enzyme system.
  • the surfactant may be a synthetic surfactant or a biosurfactant which is mircrobially synthesized e.g. from bacteria, fungi or other microbe.
  • the biosurfactant preferably comprises a microbially-derived biosurfactant.
  • it comprises a glycolipid biosurfactant which may be a rhamnolipid or sophorolipid or trehalolipid or a mannosylerythritol lipid (MEL).
  • MEL mannosylerythritol lipid
  • the biosurfactant may advantageously comprise a cellobiose, peptide based biosurfactants, lipoproteins and lipopeptides e.g. surfactin, fatty acids e.g.
  • corynomucolic acids preferably with hydrocarbon chain C12-C14
  • phospholipids e.g. Phosphatidylethanolamine produced by Rhodococcus erythropolis grown on n-alkane resulted in the lowering of interfacial tension between water and hexadecane to less than 1 mN m-1 and CMC of 30 mg L-1 (Kretschner et al., 1982) and Spiculisporic acid; polymeric biosurfactants including emulsan, liposan, mannoprotein and polysaccharide-protein complexes.
  • the biosurfactant comprises a rhamnolipid.
  • the surfactant may be present by weight in the compositions at a level of from 3 to 85% by weight, preferably from 3 to 60% by weight, more preferably from 3 to 40% by weight, most preferably from 3 to 35% by weight.
  • the anionic surfactant is present at a level of from 0.1 to 95% by weight, preferably from 1 to 50% by weight, more preferably from 1.5 to 25% by weight based on total weight of surfactants present.
  • the surfactant is an anionic surfactant.
  • Anionic surfactants are defined herein as amphiphilic molecules comprising one or more functional groups that exhibit a net anionic charge when in aqueous solution at the normal wash pH of between 6 and 11.
  • Preferred anionic biosurfactants are rhamnolipds and lactonic forms of sophorolipids. Biosurfactants which are not expressed biologically in anionic form but have been modified to provide/improve anionic properties are included in the invention.
  • Preferred synthetic anionic surfactants are the alkali metal salts of organic sulphur reaction products having in their molecular structure an alkyl radical containing from about 6 to 24 carbon atoms and a radical selected from the group consisting of sulphonic and sulphuric acid ester radicals.
  • anionic surfactant hereinafter described can be used, such as alkyl ether sulphates, soaps, fatty acid ester sulphonates, alkyl benzene sulphonates, sulphosuccinate esters, primary alkyl sulphates, olefin sulphonates, paraffin sulphonates and organic phosphate; preferred anionic surfactants are the alkali and alkaline earth metal salts of fatty acid carboxylates, fatty alcohol sulphates, preferably primary alkyl sulfates, more preferably they are ethoxylated, for example alkyl ether sulfates; and alkylbenzene sulfonates or mixtures thereof.
  • Amphoteric surfactants and/or zwitterionic surfactants may be present in the compositions according to the invention.
  • the pH of the wash liquor is preferably of between 6 and 10.
  • an amphoteric or zwitterionic surfactant is present at a level of from 0.1 to 20% by weight, more preferably from 0.25 to 15% by weight, even more preferably from 0.5 to 10% by weight.
  • Suitable zwitterionic surfactants are exemplified as those which can be broadly described as derivatives of aliphatic quaternary ammonium, sulfonium and phosphonium compounds with one long chain group having about 8 to about 18 carbon atoms and at least one water solubilizing radical selected from the group consisting of sulfate, sulfonate, carboxylate, phosphate or phosphonate.
  • R 1 (R 2 ) x Y + R 3 Z - wherein R 1 contains an alkyl, alkenyl or hydroxyalkyl group with 8 to 18 carbon atoms, from 0 to 10 ethylene-oxy groups or from 0 to 2 glyceryl units; Y is a nitrogen, sulfur or phosphorous atom; R 2 is an alkyl or hydroxyalkyl group with 1 to 3 carbon atoms; x is 1 when Y is a sulfur atom and 2 when Y is a nitrogen or phosphorous atom; R 3 is an alkyl or hydroxyalkyl group with 1 to 5 carbon atoms and Z is a radical selected from the group consisting of sulfate, sulfonate, carboxylate, phosphate or phosphonate.
  • Preferred amphoteric surfactants are amine oxides, for example coco dimethyl amine oxide.
  • Preferred zwitterionic surfactants are betaines, and especially amidobetaines.
  • Preferred betaines are C 8 to C 18 alkyl amidoalkyl betaines, for example coco amido betaine. These may be included as co-surfactants, preferably present in an amount of from 0 to 10 wt %, more preferably 1 to 5 wt %, based on the weight of the total composition.
  • Preferred amphoteric or zwitterionic surfactants for incorporation in the composition according to the present invention are betaine surfactants. Examples of these are mentioned in the following list.
  • the sulfatobetaines such as 3-(dodecyldimethylammonium)-1-propane sulfate; and 2-(cocodimethylammonium)-1-ethane sulfate.
  • the sulfobetaines such as: 3-(dodecyldimethyl-ammonium)-2-hydroxy-1-propane sulfonate; 3-(tetradecyl-dimethylammonium)-1-propane sulfonate; 3-(C 12 -C 14 alkyl-amidopropyldimethylammonium)-2-hydroxy-1-propane sulfonate; and 3-(cocodimethylammonium)-1-propane sulfonate.
  • the carboxybetaines such as (dodecyldimethylammonium) acetate (also known as lauryl betaine); (tetradecyldimethylammonium) acetate (also known as myristyl betaine); (cocodimethylammonium) acetate (also known as coconut betaine); (oleyldimethylammonium) acetate (also known as oleyl betaine); (dodecyloxymethyldimethylammonium) acetate; and (cocoamidopropyldimethylammonium) acetate (also known as cocoamido-propyl betaine or CAPB).
  • dodecyldimethylammonium acetate also known as lauryl betaine
  • tetradecyldimethylammonium) acetate also known as myristyl betaine
  • cocodimethylammonium) acetate also known as coconut betaine
  • oleyldimethylammonium
  • the sulfoniumbetaines such as: (dodecyldimethylsulfonium) acetate; and 3-(cocodimethyl-sulfonium)-1-propane sulfonate.
  • the phosphoniumbetaines such as 4-(trimethylphosphonium)-1-hexadecane sulfonate; 3-(dodecyldimethylphosphonium)-1-propanesulfonate; and 2-(dodecyldimethylphosphonium)-1-ethane sulfate.
  • compositions according to the present invention preferably comprise carboxybetaines or sulphobetaines as amphoteric or zwitterionic surfactants, or mixtures thereof. Especially preferred is lauryl betaine.
  • compositions may further comprise, colorants, pearlisers and/or opacifiers, and shading dye.
  • detergent formulations according to the invention were tested to determine their ability to treat i.e. remove beef fat stains from cotton fabric.
  • Test Mixture according to the invention Composition A 5 mg/L 100 ⁇ l Arginine dilution* 20 ⁇ l Distilled water 60 ⁇ l *Arginine diluted to the following mg/ml concentrations in distilled water: 0.16, 0.32, 0.64, 1.28, 2.56, 5.12 and 10.24.
  • Control Mixture Compostion A 5 mg/L 100 ⁇ l Distilled water 100 ⁇ l
  • Stain removal is measured in terms of Remission units or a Remission index. For a visible (by the human eye) effect, effective stain removal is preferably represented by remission equal to or greater than 2 Remission units and more preferably greater or equal to 5 units.
  • figure 1 is a Graph displaying the average SRI for replicates 1-4 from Table 1 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • the tergotometer (SR Lab Instruments) allows a scaled reproduction of larger agitator type washers. This device was used to assess the cleaning activity of arginine on different fat-based stained cloth in Composition A.
  • Arginine was applied using two different approaches: (i) by including it in the formulation containing wash mixture or (ii) pre-treating the cloth with a solution of arginine before washing.
  • the volume was made up to 500 ml with demineralised water.
  • the volume was made up to 500 ml with demineralised water.
  • the volume was made up to 500 ml with demineralised water.
  • Table 2 Tergotometerassay using CS46B stained cloth washed with 1 mg/ml and 10 mg/ml arginine in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergotometerpot).
  • Table 2 is a Bar chart displaying the average SRI for replicates 1-4 from Table 2 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • Table 3 Tergotometerassay using CS46B stained cloth pre-treated with 1 mg/ml and 10 mg/ml arginine and then washed in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergotometerpot).
  • Results of Table 3 are shown in Figure 3 : a Bar chart displaying the average SRI for replicates 1-4 from Table 3 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • Table 4 Tergotometerassay using Lard & Violet Dye stained cloth washed with 1 mg/ml and 10 mg/ml arginine in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergotometerpot).
  • Results of table 4 are shown in Figure 4 : a Bar chart displaying the average SRI for replicates 1-4 from Table 4 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • Table 5 Tergotometerassay using Lard & Violet Dye stained cloth pre-treated with 1 mg/ml and 10 mg/ml arginine and then washed in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergotometerpot).
  • Table 5 The results of table 5 are shown in Figure 5 : a Bar chart displaying the average SRI for replicates 1-4 from Table 5 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • Table 6 Tergotometerassay using Hamburger Grease & Violet Dye stained cloth washed with 1 mg/ml and 10 mg/ml arginine in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergotometerpot).
  • Table 6 The results of table 6 are shown in Figure 6 : a Bar chart displaying the average SRI for replicates 1-4 from Table 6 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • Table 7 Tergotometerassay using Hamburger Grease & Violet Dye stained cloth pre-treated with 1 mg/ml and 10 mg/ml arginine and then washed in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergotometerpot).
  • Table 7 The results of table 7 are shown in Figure 7 : a Bar chart displaying the average SRI for replicates 1-4 from Table 7 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • Table 8 Tergo-O-tometer assay using Artificial Sebum stained cloth washed with 1 mg/ml and 10 mg/ml arginine in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergo-O-tometer pot).
  • Table 8 The results of table 8 are shown in Figure 8 : a Bar chart displaying the average SRI for replicates 1-4 from Table 8 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • arginine improves removal of the fat-based stains tested.
  • Pre-treatment of the stained cloth with arginine prior to washing in a surfactant containing composition A also improves stain removal.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)

Description

  • This invention relates to fabric stain removal methods for ambient-active fat/oil based stains, particularly but not exclusively as a pre-treatment or direct application.
  • DE 19 42 236 A1 , US 3 707 505 A , US 5 306 444 A , EP 2 305 785 A1 , US 2010/0261631 A1 , US 2006/0100115 A1 , and WO 95/03389 A1 all refer to detergent compositions comprising an arginine compound and a surfactant.
  • In many climates and in developing countries, aqueous substrate cleaning is performed at cold or ambient temperatures. These temperatures are a challenge for fat/oil stain removal technology which relies on water temperatures of 40 - 70 degrees. In the case of modern washing machines, stain removal mainly relies largely on the heating of water above ambient temperatures in the washing machine. This accounts for a large proportion of the laundry related greenhouse gas footprint which needs reducing for environmental reasons.
  • The objective of the invention is the removal of fabric stains from stained fabric, where the fabric stains comprise fat/oil.
  • In a first aspect, the invention provides a method for removing a stain comprising fat/oil from a stained fabric, comprising the step of applying to the stain, a fabric stain removal composition comprising an arginine compound and a surfactant.
  • In a second aspect, the invention provides a method of the first aspect of the invention, wherein the step of applying the fabric stain removal composition is a pre-treatment step using a pre-treatment device, wherein the pre-treatment device comprises (i) a storage chamber storing said fabric stain removal composition and (ii) a dispenser for locally applying said fabric stain removal composition to a stain on a fabric.
  • In a third aspect, the invention provides use of arginine compound, preferably in combination with a surfactant, in the removal of oil/fat stains from a stained fabric, preferably in the removal of fat stains, at ambient temperatures.
  • With the invention, the removal of oil/fat stains at low temperatures is radically improved and so offers improved laundry cleaning in regions where ambient washing occurs out of habit or necessity. Improved washing performance at lower temperatures is generally desirable but increased low temperature performance may also help inhibit the adoption of hot water washing in these countries, a rising trend as standards of living increase and more people are able to afford washing machines. The invention provides stain removal performance of fat based soil and/or stains in an ambient temperature cleaning processes (with low temperature wash liquor) without serious consideration to the temperature sensitivity of ingredients during storage. The formulation can therefore be designed more freely, on the basis of other considerations.
  • As used herein, the term "substrate" includes fabric, and clothing and other surfaces such as cutlery, crockery and other domestic hard surfaces.
  • As used herein, the term "arginine compound" is intended to include any suitable arginine compound, including stereoisomeric and racemic forms, derivatives, and substituted derivative and mixtures thereof.
  • The term "ambient-active" is intended to mean less that 25 degrees Celcius and preferably 22 degrees Celcius or less, more preferably 15 degrees or less but always greater than 1 degree Celcius and "active" means effective in achieving stain removal.
  • As used herein "stain removal" is means removal as measured in terms of Remission units or a Remission index. For a visible (by the human eye) effect, effective stain removal is represented by remission equal to or greater than 2 Remission units and preferably greater or equal to 5 units.
  • As used herein, the abbreviation "wt%" means "% by weight". Unless specified otherwise, all percentages mentioned herein are by weight calculated relative to the total composition.
  • The stain may comprise oil or fat, preferably fat. However, it is often found that other biological material may be included in the stain.
  • The method of the invention preferably comprises an aqueous washing process. Accordingly it is preferred that the method comprises the step of adding water to the composition to form an aqueous wash liquor
  • Preferably the method comprises localised application of the composition to a stain or stained area of the fabric. The method may be pre-treatment method, and be followed by a subsequent aqueous washing step. Pre-treatment steps may take place without further addition of any water (beyond any contained in the composition). Alternatively or additionally, the pre-treatment process may comprise the step of soaking the substrate in an aqueous solution to which the treatment composition has been added.
  • The second step of the method of the invention may be a 'main' wash and may be a manual washing process or a washing process in a washing machine. The second step may use any suitable detergent composition. Preferably this detergent composition comprises one or more surfactants and/or other functional ingredients, adjuncts etc. as described below.
  • In the case of pre-treatment according to the invention, subsequent steps may not require further application of the arginine compound.
  • Preferably the method of the invention is less than 90 minutes in duration, more preferably less than 60 minutes and most preferably less than 30 minutes. In pre-treatment embodiments, the pre-treatment step is preferably less than 5 minutes, and more preferably less than 2 minutes.
  • The pre-treatment device may be by any suitable device such as roll-on applicator or tube, sprays, aerosols, pastes, a pump-operated dispenser or the like. The pre-treatment device may comprise a scrubbing member having brush, bristles, tufts, projections, embossments etc or any combination thereof to further aid application of the detergent composition to a substrate.
  • Preferably the treatment composition is ambient-active. Accordingly, the temperature of the wash liquor step of aqueous washing process is therefore less than 40 °C and preferably less than 30 °C and more preferably less than 25 °C and more preferably less than or equal to 22 °C further more preferably 15°C or less at all times during the washing but excluding drying. Encouraging low temperature wash liquor is advantageous environmentally and financially.
  • The treatment composition of the invention and/or any detergent composition used subsequently may comprise any of the following ingredients.
  • Compositions may comprise enzymes. The enzymes are preferably present at 0.001 - 5%wt more preferably 0.01 - 3%.
  • Enzymes may be from animal, vegetable, bacterial origin (derived from bacteria) or fungal origin (derived from fungus) however enzymes from bacterial origin are preferred. Chemically modified or protein engineered mutants are included. Genes encoding such enzymes can be transferred from one host to a preferred expression production host which may or may not be the same as the original host. As used herein the term "enzyme" includes enzyme variants (produced, for example, by recombinant techniques) are included. Examples of such enzyme variants are disclosed, e.g., in EP 251,446 (Genencor), WO 91/00345 (Novo Nordisk), EP 525,610 (Solvay) and WO 94/02618 (Gist-Brocades NV).
  • The one or more enzymes preferably comprise a protease. Preferred proteases are serine proteases or metallo proteases, preferably an alkaline microbial protease or a trypsin-like protease.
  • Commercially available protease enzymes include Alcalase™, Savinase™, Primase™, Duralase™, Dyrazym™, Esperase™, Everlase™, Polarzyme™, and Kannase™, (Novozymes A/S), Maxatase™, Maxacal™, Maxapem™, Properase™, Purafect™, Purafect OxP™, FN2™, and FN3™ (Genencor International Inc.).
  • The one or more enzymes preferably comprises an amylase. Suitable amylases (alpha and/or beta) include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, alpha-amylases obtained from Bacillus, e.g. a special strain of B. licheniformis, described in more detail in GB 1,296,839 , or the Bacillus sp. strains disclosed in WO 95/026397 or WO 00/060060 .
  • Commercially available amylases are Duramyl™, Termamyl™, Termamyl Ultra™, Natalase™, Stainzyme™, Fungamyl™ and BAN™ (Novozymes A/S), Rapidase™ and Purastar™ (from Genencor International IncCommercially available amylases include Stainzyme™ (Novozymes).
  • The one or more enzymes preferably comprise a lipase and in such cases, the preferred lipases include first wash lipases which comprise a polypeptide having an amino acid sequence which has at least 90 percent sequence identity with the wild-type lipase derived from Humicola lanuginosa strain DSM 4109 and compared to said wild-type lipase, comprises a substitution of an electrically neutral or negatively charged amino acid within 15 A of E1 or Q249 with a positively charged amino acid; and may further comprise:
    1. (I) a peptide addition at the C-terminal;
    2. (II) a peptide addition at the N-terminal;
    3. (III) the following limitations:
      • i. comprises a negatively charged amino acid in position E210 of said wild-type lipase;
      • ii. comprises a negatively charged amino acid in the region corresponding to positions 90-101 of said wild-type lipase; and
      • iii. comprises a neutral or negatively charged amino acid at a position corresponding to N94 of said wild-type lipase; and/or
      • iv. has a negative charge or neutral charge in the region corresponding to positions 90-101 of said wild-type lipase; and
      • iv. mixtures thereof.
  • These are available under the Lipex™ brand from Novozymes. A similar enzyme from Novozymes but believed to fall outside of the above definition has been disclosed by Novozymes under the name Lipoclean™ and this is also preferred.
  • Other possible lipases include lipases from Humicola (synonym Thermomyces), e.g. from other H. lanuginosa (T. lanuginosus) strains or from H. insolens, a Pseudomonas lipase, e.g. from P. alcaligenes or P. pseudoalcaligenes, P. cepacia, P. stutzeri, P. fluorescens, Pseudomonas sp. strain SD 705 ( WO 95/06720 and WO 96/27002 ), P. wisconsinensis, a Bacillus lipase, e.g. from B. subtilis (Dartois et al. (1993), Biochemica et Biophysica Acta, 1131, 253-360), B. stearothermophilus ( JP 64/744992 ) or B. pumilus ( WO 91/16422 ).
  • Commercially available lipase enzymes include Lipolase™ and Lipolase Ultra™, and the Bacterial enzyme, Lipomax ® ex Genecor. This is a bacterially derived Lipase, of variant M21L of the lipase of Pseudomonas alcaligenes as described in WO 94/25578 to Gist-Brocades (M.M.M.J. Cox, H.B.M. Lenting, L.J.S.M. Mulleners and J.M. van der Laan).
  • The one or more enzymes preferably comprise a phospholipase classified as EC 3.1.1.4 and/or EC 3.1.1.32. As used herein, the term phospholipase is an enzyme which has activity towards phospholipids. Phospholipids, such as lecithin or phosphatidylcholine, consist of glycerol esterified with two fatty acids in an outer (sn-1) and the middle (sn-2) positions and esterified with phosphoric acid in the third position; the phosphoric acid, in turn, may be esterified to an amino-alcohol. Phospholipases are enzymes which participate in the hydrolysis of phospholipids. Several types of phospholipase activity can be distinguished, including phospholipases A1 and A2 which hydrolyze one fatty acyl group (in the sn-1 and sn-2 position, respectively) to form lysophospholipid; and lysophospholipase (or phospholipase B) which can hydrolyze the remaining fatty acyl group in lysophospholipid. Phospholipase C and phospholipase D (phosphodiesterases) release diacyl glycerol or phosphatidic acid respectively.
  • The one or more enzymes preferably comprise a cutinase. classified in EC 3.1.1.74. The cutinase used according to the invention may be of any origin. Preferably cutinases are of microbial origin, in particular of bacterial, of fungal or of yeast origin.
  • The one or more enzymes preferably comprise a cellulase preferably including those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g. the fungal cellulases produced from Humicola insolens, Thielavia terrestris, Myceliophthora thermophila, and Fusarium oxysporum disclosed in US 4,435,307 , US 5,648,263 , US 5,691,178 , US 5,776,757 , WO 89/09259 , WO 96/029397 , and WO 98/012307 . Commercially available cellulases include Celluzyme™, Carezyme™, Endolase™, Renozyme™ (Novozymes A/S), Clazinase™ and Puradax HA™ (Genencor International Inc.), and KAC-500(B)™ (Kao Corporation).
  • The one or more enzymes preferably comprise a peroxidase/oxidase are especially of bacterial origin. Chemically modified or protein engineered mutants are included. An example of an oxidative bacterium is, but not limited to, are Aeromonas sp wherefrom oxidases can be sourced.
  • The one or more enzymes preferably comprise a pectate lyase (also called polygalacturonate lyases): Examples of pectate lyases include pectate lyases that have been cloned from different bacterial genera such as Erwinia, Pseudomonas, Klebsiella and Xanthomonas, as well as from Bacillus subtilis (Nasser et al. (1993) FEBS Letts. 335:319-326) and Bacillus sp. YA-14 (Kim et al. (1994) Biosci. Biotech. Biochem. 58:947-949). Purification of pectate lyases with maximum activity in the pH range of 8-10 produced by Bacillus pumilus (Dave and Vaughn (1971) J. Bacteriol. 108:166-174), B. polymyxa (Nagel and Vaughn (1961) Arch. Biochem. Biophys. 93:344-352), B. stearothermophilus (Karbassi and Vaughn (1980) Can. J. Microbiol. 26:377-384), Bacillus sp. (Hasegawa and Nagel (1966) J. Food Sci. 31:838-845) and Bacillus sp. RK9 (Kelly and Fogarty (1978) Can. J. Microbiol. 24:1164-1172) have also been described. Any of the above, as well as divalent cation-independent and/or thermostable pectate lyases, may be used in practicing the invention. In preferred embodiments, the pectate lyase comprises the pectate lyase disclosed in Heffron et al., (1995) Mol. Plant-Microbe Interact. 8: 331-334 and Henrissat et al., (1995) Plant Physiol. 107: 963-976. Specifically contemplated pectatel lyases are disclosed in WO 99/27083 and WO 99/27084 . Other specifically contemplated pectate lyases (derived from Bacillus licheniformis) are disclosed in US patent no. 6,284,524 (which document is hereby incorporated by reference). Specifically contemplated pectate lyase variants are disclosed in WO 02/006442 , especially the variants disclosed in the Examples in WO 02/006442 (which document is hereby incorporated by reference). Examples of commercially available alkaline pectate lyases include BIOPREP™ and SCOURZYME™ L from Novozymes A/S, Denmark.
  • The one or more enzymes preferably comprise a Mannanase: Examples of mannanases (EC 3.2.1.78) include mannanases of bacterial and fungal origin. In a specific embodiment the mannanase is derived from a strain of the filamentous fungus genus Aspergillus, preferably Aspergillus niger or Aspergillus aculeatus ( WO 94/25576 ). WO 93/24622 discloses a mannanase isolated from Trichoderma reseei. Mannanases have also been isolated from several bacteria, including Bacillus organisms. For example, Talbot et al., Appl. Environ. Microbiol., Vol.56, No. 11, pp. 3505-3510 (1990) describes a beta-mannanase derived from Bacillus stearothermophilus. Mendoza et al., World J. Microbiol. Biotech., Vol. 10, No. 5, pp. 551-555 (1994) describes a beta-mannanase derived from Bacillus subtilis. JP-A-03047076 discloses a beta-mannanase derived from Bacillus sp. JP-A-63056289 describes the production of an alkaline, thermostable beta-mannanase. JP-A-63036775 relates to the Bacillus microorganism FERM P-8856 which produces beta-mannanase and beta-mannosidase. JP-A-08051975 discloses alkaline beta-mannanases from alkalophilic Bacillus sp. AM-001. A purified mannanase from Bacillus amyloliquefaciens is disclosed in WO 97/11164 . WO 91/18974 describes a hemicellulase such as a glucanase, xylanase or mannanase active. Contemplated are the alkaline family 5 and 26 mannanases derived from Bacillus agaradhaerens, Bacillus licheniformis, Bacillus halodurans, Bacillus clausii, Bacillus sp., and Humicola insolens disclosed in WO 99/64619 . Especially contemplated are the Bacillus sp. mannanases concerned in the Examples in WO 99/64619 . Examples of commercially available mannanases include Mannaway™ available from Novozymes A/S Denmark.
  • The enzyme and any perfume/fragrance or pro-fragrance present may show some interaction and should be chosen such that this interaction is not negative. Some negative interactions may be avoided by encapsulation of one or other of enzyme and pro-fragrance and/or other segregation within the product. The enzymes may be provided as an enzyme system.
  • The surfactant may be a synthetic surfactant or a biosurfactant which is mircrobially synthesized e.g. from bacteria, fungi or other microbe. The biosurfactant preferably comprises a microbially-derived biosurfactant. Preferably it comprises a glycolipid biosurfactant which may be a rhamnolipid or sophorolipid or trehalolipid or a mannosylerythritol lipid (MEL). Alternatively, the biosurfactant may advantageously comprise a cellobiose, peptide based biosurfactants, lipoproteins and lipopeptides e.g. surfactin, fatty acids e.g. corynomucolic acids (preferably with hydrocarbon chain C12-C14), phospholipids e.g. Phosphatidylethanolamine produced by Rhodococcus erythropolis grown on n-alkane resulted in the lowering of interfacial tension between water and hexadecane to less than 1 mN m-1 and CMC of 30 mg L-1 (Kretschner et al., 1982) and Spiculisporic acid; polymeric biosurfactants including emulsan, liposan, mannoprotein and polysaccharide-protein complexes.
  • Preferably the biosurfactant comprises a rhamnolipid.
  • The surfactant may be present by weight in the compositions at a level of from 3 to 85% by weight, preferably from 3 to 60% by weight, more preferably from 3 to 40% by weight, most preferably from 3 to 35% by weight.
  • Preferably the anionic surfactant is present at a level of from 0.1 to 95% by weight, preferably from 1 to 50% by weight, more preferably from 1.5 to 25% by weight based on total weight of surfactants present.
  • Preferably the surfactant is an anionic surfactant.
  • Anionic surfactants are defined herein as amphiphilic molecules comprising one or more functional groups that exhibit a net anionic charge when in aqueous solution at the normal wash pH of between 6 and 11.
  • Preferred anionic biosurfactants are rhamnolipds and lactonic forms of sophorolipids. Biosurfactants which are not expressed biologically in anionic form but have been modified to provide/improve anionic properties are included in the invention.
  • Preferred synthetic anionic surfactants are the alkali metal salts of organic sulphur reaction products having in their molecular structure an alkyl radical containing from about 6 to 24 carbon atoms and a radical selected from the group consisting of sulphonic and sulphuric acid ester radicals.
  • Although any anionic surfactant hereinafter described can be used, such as alkyl ether sulphates, soaps, fatty acid ester sulphonates, alkyl benzene sulphonates, sulphosuccinate esters, primary alkyl sulphates, olefin sulphonates, paraffin sulphonates and organic phosphate; preferred anionic surfactants are the alkali and alkaline earth metal salts of fatty acid carboxylates, fatty alcohol sulphates, preferably primary alkyl sulfates, more preferably they are ethoxylated, for example alkyl ether sulfates; and alkylbenzene sulfonates or mixtures thereof.
  • Amphoteric surfactants and/or zwitterionic surfactants may be present in the compositions according to the invention. For amphoteric the pH of the wash liquor is preferably of between 6 and 10. Preferably an amphoteric or zwitterionic surfactant is present at a level of from 0.1 to 20% by weight, more preferably from 0.25 to 15% by weight, even more preferably from 0.5 to 10% by weight.
  • Suitable zwitterionic surfactants are exemplified as those which can be broadly described as derivatives of aliphatic quaternary ammonium, sulfonium and phosphonium compounds with one long chain group having about 8 to about 18 carbon atoms and at least one water solubilizing radical selected from the group consisting of sulfate, sulfonate, carboxylate, phosphate or phosphonate. A general formula for these compounds is:

            R1(R2)xY+R3Z-

    wherein R1 contains an alkyl, alkenyl or hydroxyalkyl group with 8 to 18 carbon atoms, from 0 to 10 ethylene-oxy groups or from 0 to 2 glyceryl units; Y is a nitrogen, sulfur or phosphorous atom; R2 is an alkyl or hydroxyalkyl group with 1 to 3 carbon atoms; x is 1 when Y is a sulfur atom and 2 when Y is a nitrogen or phosphorous atom; R3 is an alkyl or hydroxyalkyl group with 1 to 5 carbon atoms and Z is a radical selected from the group consisting of sulfate, sulfonate, carboxylate, phosphate or phosphonate.
  • Preferred amphoteric surfactants are amine oxides, for example coco dimethyl amine oxide. Preferred zwitterionic surfactants are betaines, and especially amidobetaines. Preferred betaines are C8 to C18 alkyl amidoalkyl betaines, for example coco amido betaine. These may be included as co-surfactants, preferably present in an amount of from 0 to 10 wt %, more preferably 1 to 5 wt %, based on the weight of the total composition.
  • Preferred amphoteric or zwitterionic surfactants for incorporation in the composition according to the present invention are betaine surfactants. Examples of these are mentioned in the following list.
    The sulfatobetaines, such as 3-(dodecyldimethylammonium)-1-propane sulfate; and 2-(cocodimethylammonium)-1-ethane sulfate.
    The sulfobetaines, such as: 3-(dodecyldimethyl-ammonium)-2-hydroxy-1-propane sulfonate; 3-(tetradecyl-dimethylammonium)-1-propane sulfonate; 3-(C12-C14 alkyl-amidopropyldimethylammonium)-2-hydroxy-1-propane sulfonate; and 3-(cocodimethylammonium)-1-propane sulfonate.
  • The carboxybetaines, such as (dodecyldimethylammonium) acetate (also known as lauryl betaine); (tetradecyldimethylammonium) acetate (also known as myristyl betaine); (cocodimethylammonium) acetate (also known as coconut betaine); (oleyldimethylammonium) acetate (also known as oleyl betaine); (dodecyloxymethyldimethylammonium) acetate; and (cocoamidopropyldimethylammonium) acetate (also known as cocoamido-propyl betaine or CAPB).
  • The sulfoniumbetaines, such as: (dodecyldimethylsulfonium) acetate; and 3-(cocodimethyl-sulfonium)-1-propane sulfonate.
  • The phosphoniumbetaines, such as 4-(trimethylphosphonium)-1-hexadecane sulfonate; 3-(dodecyldimethylphosphonium)-1-propanesulfonate; and 2-(dodecyldimethylphosphonium)-1-ethane sulfate.
  • The compositions according to the present invention preferably comprise carboxybetaines or sulphobetaines as amphoteric or zwitterionic surfactants, or mixtures thereof. Especially preferred is lauryl betaine.
  • Further optional ingredients include additional surfactants e.g non ionic and cationic surfactants, viscosity modifiers, foam boosting agents, preservatives (e.g. bactericides), pH buffering agents, polyelectrolytes, anti-shrinking agents, anti-wrinkle agents, anti-oxidants, sunscreens, anti-corrosion agents, drape imparting agents, anti-static agents and ironing aids. The compositions may further comprise, colorants, pearlisers and/or opacifiers, and shading dye. Fluorescent Agents
  • The invention will now be further described with reference to the following nonlimiting examples.
  • Examples
  • All values throughout are wt%/.
  • Enzyme-free Detergent formulation A
  • Ingredient % by weight
    Non-ionic surfactant Neodol 25-7 6.2
    Anionic surfactant LAS acid 11.8
    Anionic surfactant SLES 3EO 6.5
    Lauric Fatty Acid P5908 5.2
    Glycerol 5.0
    Monopropylene Glycol 9.0
    Citric acid 3.9
    Minors 2.0
    Water balance to 100
  • Wherein:
    Neodol 25-7 ex.Shell = C12-C15 alcohol 7-ethoxylate
    LAS acid = C10-C14 alkyl benzene sulphonic acid;
    SLES = C12-C13 alcohol 3-ethoxylate sulphate, Na salt: = sodium lauryl ether sulphate (with on average 3 ethylene oxide groups);
  • Example 1
  • In this example, detergent formulations according to the invention were tested to determine their ability to treat i.e. remove beef fat stains from cotton fabric.
  • End-point Stain Removal Assay Reagents:
    • CS46B (Beef fat, coloured) stained cloth (Testfabrics Inc.) was hole punched into discs and transferred to 300 µl 96 well plates.
    • Composition A
    • DL-Arginine (Sigma Cat No. 11020, EC Number: 230-571-3)
    Procedure:
    • The stained cloth was pre-rinsed (before adding to the well plates) to remove any residual free stain:
      • 200 µl of distilled water was added to each well
      • Plates shaken at 900 rpm for 10 mins
      • water removed
  • Add washing mixtures as follows:
    Test Mixture according to the invention:
    Composition A 5 mg/L 100 µl
    Arginine dilution* 20 µl
    Distilled water 60 µl
    *Arginine diluted to the following mg/ml concentrations in distilled water: 0.16, 0.32, 0.64, 1.28, 2.56, 5.12 and 10.24.

    Control Mixture:
    Compostion A 5 mg/L 100 µl
    Distilled water 100 µl
    • Reactions were incubated at 22 degrees for 1 hour with shaking at 900 rpm.
    • The cloth was rinsed by adding 200 µl of distilled water to each well followed by shaking at 900 rpm for 5 minutes. The liquor was then removed. This procedure was repeated four consecutive times.
    • The cloth was dried for 3 hours at 40 degrees
    • After drying, the stain plates were digitally scanned and their deltaE measured. This value is used to express cleaning effect and is defined as the colour difference between a white cloth and that of the stained cloth after being washed. Mathematically, the definition of deltaE is: deltaE = ΔL 2 + Δa 2 + Δb 2 1 / 2
      Figure imgb0001
      wherein ΔL is a measure of the difference in darkness between the washed and white cloth; Δa and Δb are measures for the difference in redness and yellowness respectively between both cloths. From this equation, it is clear that the lower the value of deltaE, the whiter the cloth will be. With regard to this colour measurement technique, reference is made to Commission International de I'Eclairage (CIE); Recommendation on Uniform Colour Spaces, colour difference equations, psychometric colour terms, supplement no. 2 to CIE Publication, no. 15, Colormetry, Bureau Central de la CIE, Paris 1978.
    Results
  • In the tables below the cleaning effect is expressed in the form of a stain removal index (SRI): SRI = 100 deltaE.
    Figure imgb0002
  • The higher the SRI the cleaner the cloth, SRI = 100 (white). "Stain removal" is measured in terms of Remission units or a Remission index. For a visible (by the human eye) effect, effective stain removal is preferably represented by remission equal to or greater than 2 Remission units and more preferably greater or equal to 5 units.
  • Table 1: End-point stain removal assays using CS46B stained cloth treated with a range of arginine concentrations in MTS24 formulation. Four replicates were performed in parallel on the same 96 well plate. The plates were scanned and the SRI values calculated
    Rep 1 Rep 2 Rep 3 Rep 4 Average
    Arginine (mg/ml) SRI SRI SRI SRI SRI STDEV
    0.0 65.6 64.2 66.1 64.0 65.0 1.0
    0.16 72.5 72.0 70.0 72.5 71.7 1.2
    0.32 74.8 73.3 74.2 74.8 74.3 0.7
    0.64 75.9 75.3 72.7 74.9 74.7 1.4
    1.28 77.1 76.2 76.3 76.3 76.5 0.4
    2.56 78.1 76.4 77.5 78.8 77.7 1.0
    5.12 80.2 79.6 81.8 81.6 80.8 1.0
    10.24 81.6 81.9 82.7 81.8 82.0 0.5
  • The results of table 1 are shown in figure 1 which is a Graph displaying the average SRI for replicates 1-4 from Table 1 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • These results demonstrate that arginine removes the CS46B stain in dose dependent manner
  • Tergotometer Assays
  • The tergotometer (SR Lab Instruments) allows a scaled reproduction of larger agitator type washers. This device was used to assess the cleaning activity of arginine on different fat-based stained cloth in Composition A.
  • Stained Cloth:
    • CS46B (Beef fat, coloured) (Testfabrics Inc.)
    • Hamburger Grease & Violet Dye (Warwick Equest)
    • Lard & Violet Dye (Warwick Equest)
    • Artificial Sebum & Carbon Black Dye (in house)
    • Composition A (+) surfactants (-) enzymes
    • DL-Arginine (Sigma Cat No. 11020, EC Number: 230-571-3)
    Procedure:
  • Two 10 X 10 cm pieces of the same stained cloth were added to each Tergotometer pot. Two pieces of 10 X 10 cm unstained, white cloth was also added to each Tergotometer pot to simulate a typical washing load. Arginine was applied using two different approaches: (i) by including it in the formulation containing wash mixture or (ii) pre-treating the cloth with a solution of arginine before washing.
  • -Arginine containing wash:
  • Stained cloths were transferred into 1 litre Tergotometer pots containing:
    100 mg/ml Arginine (pH 8.0) 50 ml (10 mg/ml), 5 ml (1 mg/ml)
    Compostion A 0.57 ml
    French Hardness (50X) 10 ml
  • The volume was made up to 500 ml with demineralised water.
  • Wash conditions: 1 hour at 22 C
  • -Arginine Pre-treatment wash:
  • Stained cloths were pre-treated by soaking in solutions of 1 mg/ml or 10 mg/ml arginine in water (pH 8.0) for 5 mins before being transferred to Tergotometer pots containing:
    Composition A 0.57 ml
    French Hardness (50X) 10 ml
  • The volume was made up to 500 ml with demineralised water.
  • Wash conditions: 1 hour at 22 C
  • -Control Wash:
  • Stained cloths were transferred into 1 litre Tergotometerpots containing:
    Composition A 0.57 ml
    French Hardness (50X) 10 ml
  • The volume was made up to 500 ml with demineralised water.
  • Wash conditions: 1 hour at 22 C
  • After washing the cloths were rinsed for 5 X 2 mins in demineralised water and air dried over night.
  • When fully dry, the cloths were digitally scanned, their delta E measured and SRI calculated as described previously.
  • Results
  • In the tables below the cleaning effect is expressed in the form of a stain removal index (SRI): SRI = 100 deltaE.
    Figure imgb0003
  • The higher the SRI the cleaner the cloth, SRI = 100 (white).
  • Table 2: Tergotometerassay using CS46B stained cloth washed with 1 mg/ml and 10 mg/ml arginine in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergotometerpot).
    SRI(1) SRI(2) SRI(3) SRI(4) Average SRI STDEV
    (-) Arginine 72.56 71.82 70.61 68.99 71.00 1.56
    1 mg/ml Arginine 86.32 85.63 85.08 85.97 85.75 89.30
    10 mg/ml Arginine 88.92 89.50 89.06 89.73 89.30 0.38
  • The results of table 2 are shown in Figure 2 which is a Bar chart displaying the average SRI for replicates 1-4 from Table 2 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • Table 3: Tergotometerassay using CS46B stained cloth pre-treated with 1 mg/ml and 10 mg/ml arginine and then washed in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergotometerpot).
    SRI(1) SRI(2) SRI(3) SRI(4) Average SRI STDEV
    (-) Arginine 68.99 70.61 71.82 72.56 71.00 1.56
    1 mg/ml Arginine 79.89 80.10 80.12 80.48 80.15 0.25
    10 mg/ml Arginine 82.93 82.38 85.36 85.12 83.95 1.51
  • Results of Table 3 are shown in Figure 3: a Bar chart displaying the average SRI for replicates 1-4 from Table 3 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • Table 4: Tergotometerassay using Lard & Violet Dye stained cloth washed with 1 mg/ml and 10 mg/ml arginine in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergotometerpot).
    SRI(1) SRI(2) SRI(3) SRI(4) Average SRI STDEV
    (-) Arginine 47.64 46.13 45.05 46.57 46.35 1.07
    1 mg/ml Arginine 53.36 51.01 51.29 52.52 52.05 1.09
    10 mg/ml Arginine 57.04 55.22 55.84 54.21 55.58 1.18
  • Results of table 4 are shown in Figure 4: a Bar chart displaying the average SRI for replicates 1-4 from Table 4 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • Table 5: Tergotometerassay using Lard & Violet Dye stained cloth pre-treated with 1 mg/ml and 10 mg/ml arginine and then washed in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergotometerpot).
    SRI(1) SRI(2) SRI(3) SRI(4) Average SRI STDEV
    (-) Arginine 47.64 46.13 45.05 46.57 46.35 1.07
    1 mg/ml Arginine 55.22 51.50 52.23 53.22 53.04 1.62
    10 mg/ml Arginine 58.83 57.98 56.74 57.23 57.70 0.91
  • The results of table 5 are shown in Figure 5: a Bar chart displaying the average SRI for replicates 1-4 from Table 5 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • Table 6: Tergotometerassay using Hamburger Grease & Violet Dye stained cloth washed with 1 mg/ml and 10 mg/ml arginine in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergotometerpot).
    SRI(1) SRI(2) SRI(3) SRI(4) Average SRI STDEV
    (-) Arginine 52.27 48.89 51.46 52.38 51.25 1.62
    1 mg/ml Arginine 55.73 58.45 52.90 54.31 55.35 2.37
    10 mg/ml Arginine 63.48 57.45 60.10 58.56 59.90 2.62
  • The results of table 6 are shown in Figure 6: a Bar chart displaying the average SRI for replicates 1-4 from Table 6 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • Table 7: Tergotometerassay using Hamburger Grease & Violet Dye stained cloth pre-treated with 1 mg/ml and 10 mg/ml arginine and then washed in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergotometerpot).
    SRI(1) SRI(2) SRI(3) SRI(4) Average SRI STDEV
    (-) Arginine 52.27 48.89 51.46 52.38 51.25 1.62
    1 mg/ml Arginine 56.90 55.56 55.83 57.61 56.47 0.95
    10 mg/ml Arginine 58.83 57.99 59.84 56.97 58.41 1.22
  • The results of table 7 are shown in Figure 7: a Bar chart displaying the average SRI for replicates 1-4 from Table 7 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • Table 8: Tergo-O-tometer assay using Artificial Sebum stained cloth washed with 1 mg/ml and 10 mg/ml arginine in MTS24 formulation. 4 replicates were performed in parallel (2 X replicate per Tergo-O-tometer pot).
    SRI(1) SRI(2) SRI(3) SRI(4) Average SRI STDEV
    (-) Arginine 66.83 64.97 63.22 65.35 65.09 1.49
    1 mg/ml Arginine 85.76 82.26 87.81 83.84 84.92 2.40
    10 mg/ml Arginine 91.43 86.41 87.89 85.95 87.92 2.48
  • The results of table 8 are shown in Figure 8: a Bar chart displaying the average SRI for replicates 1-4 from Table 8 vs arginine concentration. Error bars display standard deviation between the four replicates for each concentration.
  • Conclusions:
  • The inclusion of arginine improves removal of the fat-based stains tested. Pre-treatment of the stained cloth with arginine prior to washing in a surfactant containing composition A also improves stain removal.

Claims (8)

  1. A method for removing a stain comprising fat/oil from a stained fabric, comprising the step of applying to the stain, a fabric stain removal composition comprising an arginine compound and a surfactant.
  2. A method according to claim 1, wherein the surfactant comprises an anionic surfactant.
  3. A method according to claim 2, where the surfactant comprises a rhamnolipid.
  4. A method according to any preceding claim, wherein said fabric stain removal composition is ambient-active.
  5. A method according to any preceding claim comprising the step of adding water to the fabric stain removal composition to form an aqueous wash liquor.
  6. A method according to any of claims 1 to 4 comprising localised application to a stain comprising fat/oil on a stained fabric, of the fabric stain removal composition as defined in claims 1-4.
  7. A method according to any preceding claim wherein the step of applying the fabric stain removal composition is a pre-treatment step using a pre-treatment device, wherein the pre-treatment device comprises (i) a storage chamber storing the fabric stain removal composition as defined in any of claims 1-4 and (ii) a dispenser for locally applying said fabric stain removal composition to a stain on a fabric.
  8. Use of an arginine compound in the removal of an oil/fat stain from a stained fabric at ambient temperatures, preferably in combination with surfactant.
EP13803053.1A 2012-12-20 2013-12-13 Method for removing fat and/or oil stains Active EP2935549B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP13803053.1A EP2935549B1 (en) 2012-12-20 2013-12-13 Method for removing fat and/or oil stains

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12198568 2012-12-20
PCT/EP2013/076514 WO2014095617A1 (en) 2012-12-20 2013-12-13 Stain removal compositions
EP13803053.1A EP2935549B1 (en) 2012-12-20 2013-12-13 Method for removing fat and/or oil stains

Publications (2)

Publication Number Publication Date
EP2935549A1 EP2935549A1 (en) 2015-10-28
EP2935549B1 true EP2935549B1 (en) 2018-09-26

Family

ID=47519903

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13803053.1A Active EP2935549B1 (en) 2012-12-20 2013-12-13 Method for removing fat and/or oil stains

Country Status (4)

Country Link
EP (1) EP2935549B1 (en)
CN (1) CN104903433A (en)
BR (1) BR112015013067B1 (en)
WO (1) WO2014095617A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102014221889B4 (en) * 2014-10-28 2023-12-21 Henkel Ag & Co. Kgaa Detergents with mannosylerythritol lipid, enhancing the cleaning performance of detergents through mannosylerythritol lipid, and washing processes using mannosylerythritol lipid
MX2018007870A (en) 2015-12-31 2018-11-09 Colgate Palmolive Co Cleansing compositions.
CN108219677A (en) * 2017-12-06 2018-06-29 王建东 A kind of tableware dryer and preparation method thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1942236A1 (en) * 1969-08-20 1971-03-04 Henkel & Cie Gmbh Enzymatic washing agents and detergents
JPS5014651B1 (en) * 1969-12-30 1975-05-29
CA2049728A1 (en) * 1990-08-24 1992-02-25 Kenji Kitamura Washing composition capable of preventing and ameliorating skin irritation
DE4324396A1 (en) * 1993-07-21 1995-01-26 Henkel Kgaa Detergents with high wettability
MXPA02003138A (en) * 1999-09-22 2002-09-30 Procter & Gamble A handheld liquid container.
WO2004061071A1 (en) * 2002-12-27 2004-07-22 Kao Corporation Detergent composition
MX2010002897A (en) * 2007-09-14 2010-04-01 Procter & Gamble Compositions for treating fabric.
CN101878290B (en) * 2007-11-28 2013-11-13 花王株式会社 Biofilm-removing agent
EP2305785A1 (en) * 2009-10-02 2011-04-06 Unilever N.V. Use of a carboxylic or amino compound as cleaning aid for hard surfaces and method of cleaning such hard surfaces

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
BR112015013067A2 (en) 2017-07-11
BR112015013067B1 (en) 2021-11-30
EP2935549A1 (en) 2015-10-28
WO2014095617A1 (en) 2014-06-26
CN104903433A (en) 2015-09-09
BR112015013067A8 (en) 2019-10-08

Similar Documents

Publication Publication Date Title
EP3341459B1 (en) Detergent compositions with lipase and biosurfactant
CN101501183B (en) Bacteria cultures and compositions comprising bacteria cultures
EP2596088B1 (en) Detergent compositions comprising biosurfactant and enzyme
EP2756063B1 (en) Detergent compositions comprising surfactant and enzyme
EP2935549B1 (en) Method for removing fat and/or oil stains
EP3344765B1 (en) Liquid detergency composition comprising lipase and protease
EP3158044B1 (en) Enzyme treatment composition
CN105887421B (en) The system of sequential enzyme delivery
CN104884598B (en) Enzyme-treated composition
AU2002231607B2 (en) Reduction of malodour from laundry
US6794350B2 (en) Reduction of malodor from laundry
EP3158046B1 (en) Stain treatment compositions
AU2002231607A1 (en) Reduction of malodour from laundry
WO2015193204A1 (en) Enzyme treatment composition
CA2438510C (en) Reduction of malodor from laundry
EP3341460A1 (en) Liquid detergency composition comprising protease and non-protease enzyme

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150528

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

17Q First examination report despatched

Effective date: 20170906

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20180425

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1046058

Country of ref document: AT

Kind code of ref document: T

Effective date: 20181015

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602013044250

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20180926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181226

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20181227

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1046058

Country of ref document: AT

Kind code of ref document: T

Effective date: 20180926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190126

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20190126

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602013044250

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181213

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

26N No opposition filed

Effective date: 20190627

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20181231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181213

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181231

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20181213

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20180926

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20180926

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20131213

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 602013044250

Country of ref document: DE

Owner name: UNILEVER GLOBAL IP LIMITED, WIRRAL, GB

Free format text: FORMER OWNER: UNILEVER N.V., ROTTERDAM, NL

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

Free format text: REGISTERED BETWEEN 20220127 AND 20220202

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231220

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20231211

Year of fee payment: 11

Ref country code: FR

Payment date: 20231221

Year of fee payment: 11

Ref country code: DE

Payment date: 20231214

Year of fee payment: 11